Oncology drugs research services

We are pleased to present the services provided by the Preclinical Development unit of Nerviano Medical Sciences to support your drug discovery and development programs.
We can help you "pick the winner" among many potential candidates generated by high-throughput discovery technologies, predict clinical outcomes from preclinical data, and strategically design and execute preclinical studies to fulfill the requirements of regulators and clinical investigators.
Our mainstream Pharma experience is available to add value to your products, reduce late attrition rate and improve cycle times.

We offer:

• high-throughput preclinical profiling and in silico ADMET prediction and modeling;
• CTA enabling packages, including safety pharmacology, genotoxicity, toxicology,ADME and pharmacokinetic GLP studies;
• bioanalysis and pharmacokinetics (PK) for preclinical and clinical studies, including assay development and validation, PK/PD and population PK data analysis;
• drug disposition packages, including the synthesis of radiolabeled compound and QWBA;
• preclinical development consultancy and preparation of regulatory documentation;
• special expertise in the design and execution of preclinical development programs for different classes of Oncology drugs.